PETALING JAYA: Duopharma Biotech Bhd
is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.
Original article here
2024-01-26
ultimate-member domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/antsomi-news/htdocs/news.antsomi.com/wp-includes/functions.php on line 6114PETALING JAYA: Duopharma Biotech Bhd is likely to see a recovery in its consumer healthcare (CHC) segment, while sales to the government sector is also expected to increase in 2024.